CLINICAL_TRIALS
trial_result
· 2023-01-26
Clinical Trial Update: Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy [Phase 2]
Summary
Phase 2 clinical trial update for Dengzhanxixin Injection in acute ischemic stroke patients undergoing reperfusion therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN